Small cell lung cancer

You have access
Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling
HONG-BEUM KIM, YONG SUB NA, SEONG-HUN KIM, HEE-JEONG LEE and SANG-GON PARK

Anticancer Research January 2026, 46 (1) 205-212; DOI: https://doi.org/10.21873/anticanres.17935
Open Access
Inhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus
YOSHIHIRO AMANO, RYOSUKE TANINO, RONG SUN, YUKARI TSUBATA, TAKESHI ISOBE and TAMIO OKIMOTO

Anticancer Research December 2025, 45 (12) 5287-5297; DOI: https://doi.org/10.21873/anticanres.17868
You have access
Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
KENJIRO TSURUOKA, YOSUKE TAMURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA, SHIGERU KAWABATA, AKIHISA IMAGAWA and YASUHITO FUJISAKA

Anticancer Research December 2024, 44 (12) 5531-5539; DOI: https://doi.org/10.21873/anticanres.17379
You have access
Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer
JEROME H. CHECK, DIANE L. CHECK, TRINA PORETTA DO, MAYA SRIVASTAVA and ETHAN CHECK

Anticancer Research February 2024, 44 (2) 659-664; DOI: https://doi.org/10.21873/anticanres.16855
Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
You have access
Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer
YOHEI MATSUI, TADAAKI YAMADA, KENJI MORIMOTO, YUKI KATAYAMA, OSAMU HIRANUMA, SHINSUKE SHIOTSU, NOBUYO TAMIYA, TAKAYUKI TAKEDA, YOSHIE MORIMOTO, MASAHIRO IWASAKU, SHINSAKU TOKUDA and KOICHI TAKAYAMA

Anticancer Research October 2022, 42 (10) 4921-4928; DOI: https://doi.org/10.21873/anticanres.15998
You have access
MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer
BETTINA SAVARESE-BRENNER, MARLENE HEUGL, BARBARA RATH, CONRADIN SCHWEIZER, EVA OBERMAYR, SANDRA STICKLER and GERHARD HAMILTON

Anticancer Research January 2022, 42 (1) 429-439; DOI: https://doi.org/10.21873/anticanres.15501
You have access
Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer
EVANGELOS DIMAKAKOS, KONSTANTINOS LIVANIOS, IOANNIS VATHIOTIS, GEORGIA GOMATOU, IOANNIS GKIOZOS, ELIAS KOTTEAS, ELIAS KAINIS and KONSTANTINOS SYRIGOS

Anticancer Research March 2021, 41 (3) 1523-1528; DOI: https://doi.org/10.21873/anticanres.14911
You have access
Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Multidrug Resistant Small Cell Lung Cancer (H69AR) In Vitro
MAŁGORZATA DRĄG-ZALESIŃSKA, JOLANTA SACZKO, ANNA CHOROMAŃSKA, ANNA SZEWCZYK, NINA REMBIAŁKOWSKA, JULITA KULBACKA and ADAM RZECHONEK

Anticancer Research July 2019, 39 (7) 3711-3718; DOI: https://doi.org/10.21873/anticanres.13519
You have access
Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer
GOUJI TOYOKAWA, KAZUKI TAKADA, TETSUZO TAGAWA, FUMIHIKO KINOSHITA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, SHINKICHI TAKAMORI, TAKAKI AKAMINE, FUMIHIKO HIRAI, YUICHI YAMADA, RYUJI HAMAMOTO, YOSHINAO ODA and YOSHIHIKO MAEHARA

Anticancer Research June 2018, 38 (6) 3707-3711; DOI: https://doi.org/10.21873/anticanres.12649

Main menu

User menu

Search

Small cell lung cancer

Pages